Search alternatives:
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 481 - 500 results of 11,369 for search '(( 10 ((nn decrease) OR (teer decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 0.48s Refine Results
  1. 481
    Fig 12 -

    Fig 12 - by Matti Viluksela (321291)

    Published 2024
    “…Proportion of tetra brominated BDEs 47, 66 and penta brominated BDE 99 decreased and that of penta brominated BDE 100 and hexa brominated BDEs 153 and 154 increased.…”
    Save to List
    Saved in:
  2. 482
    Image_4_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg

    Image_4_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  3. 483
    Image_5_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg

    Image_5_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  4. 484
    Table_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx

    Table_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  5. 485
    Image_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg

    Image_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  6. 486
    Image_3_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg

    Image_3_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  7. 487
    Image_6_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg

    Image_6_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  8. 488
    Table_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx

    Table_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  9. 489
    Image_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg

    Image_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
    Save to List
    Saved in:
  10. 490
    Immunohistochemical analysis of PDGF-BB expression in various experimental groups; showing negative expression in control group, significant increased along the fibrous septa and along the sinusoidal areas (upper insert) in TAA administrated group, significant dose related decreased expression in RBO which showing scattered expression in the sinusoidal areas, and mild expression along the incomplete septa as well as in sinusoidal areas in silymarin treated group.

    Immunohistochemical analysis of PDGF-BB expression in various experimental groups; showing negative expression in control group, significant increased along the fibrous septa and a... by Rehab F. Abdel-Rahman (11886404)

    Published 2021
    Save to List
    Saved in:
  11. 491
    Overall survival (OS) of patient with newly diagnosed AML in South Korea, from 2011 to2020 by subpopulation: (a) Overall population, (b) OS by Age group, (c) OS by Treatment, (d) OS by HSTC.

    Overall survival (OS) of patient with newly diagnosed AML in South Korea, from 2011 to2020 by subpopulation: (a) Overall population, (b) OS by Age group, (c) OS by Treatment, (d) O... by Hyun Jin Han (18592254)

    Published 2024
    Save to List
    Saved in:
  12. 492
    Fibrosis markers.

    Fibrosis markers. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  13. 493
    Acceptability and cost-effectiveness of blood sample transport by drone for HIV-testing of infants exposed to HIV in the city of Conakry, Guinea (ANRS 12407 AIRPOP)

    Acceptability and cost-effectiveness of blood sample transport by drone for HIV-testing of infants exposed to HIV in the city of Conakry, Guinea (ANRS 12407 AIRPOP) by Maxime Inghels (17160577)

    Published 2024
    Save to List
    Saved in:
  14. 494
    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR.

    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  15. 495
    Immunoblotting for JAK, STAT, and SMAD.

    Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  16. 496
    Immunoblotting for insulin sensitivity markers.

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  17. 497
    Immunoblotting FOXO1 and insulin receptors.

    Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

    Published 2024
    Save to List
    Saved in:
  18. 498
    Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx

    Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

    Published 2025
    “…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca<sup>2+</sup> concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”
    Save to List
    Saved in:
  19. 499
    Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif

    Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

    Published 2025
    “…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca<sup>2+</sup> concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”
    Save to List
    Saved in:
  20. 500
    Image 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif

    Image 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

    Published 2025
    “…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca<sup>2+</sup> concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”
    Save to List
    Saved in:

Search Tools: